Isolated Limb Perfusion in Melanoma Treatment

Summary

Isolated limb perfusion (ILP) is a regional chemotherapy technique designed to deliver high doses of cytotoxic agents directly to an affected limb while limiting systemic exposure. Originally developed in the 1950s, ILP involves surgical cannulation of the major artery and vein supplying the limb, followed by extracorporeal circulation of a heated perfusate containing melphalan, often combined with mild hyperthermia. The procedure can achieve tumour response rates exceeding 70 per cent in patients with in-transit metastases confined to an extremity, offering limb salvage in otherwise unresectable cases. Hyperthermia enhances drug uptake and tumour cell kill, while limb isolation reduces systemic toxicity. Beyond direct cytotoxicity, ILP induces immunogenic cell death, releasing tumour antigens and heat-shock proteins that may prime systemic anti-tumour immunity. Modern practice integrates ILP with evolving systemic therapies—immune checkpoint inhibitors and targeted agents—to address microscopic disease and reduce recurrence. Patient selection, technical expertise and perioperative management are critical to minimise complications such as regional toxicity, compartment syndrome and systemic leakage. Globally, ILP remains a valuable option in multidisciplinary melanoma care, particularly where novel systemic agents are inaccessible or in cases of locoregional progression despite immunotherapy.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Isolated Limb Perfusion in Melanoma Treatment publication trend

The graph below shows the total number of articles in isolated limb perfusion in melanoma treatment across all publications each year (not limited to Nature Index journals).

Technical terms

Isolated limb perfusion (ILP): A surgical technique that delivers high-dose chemotherapy to a limb via extracorporeal circulation while excluding systemic circulation.

Melphalan: An alkylating chemotherapeutic agent commonly used in ILP to induce tumour cell death.

In-transit metastasis: Tumour deposits occurring in lymphatic channels between the primary melanoma site and regional lymph nodes.

Hyperthermia: Elevation of perfusate temperature (usually to 39–41 °C) during ILP to enhance chemotherapy efficacy and tumour susceptibility.

References

  1. Isolated Limb Perfusion With Melphalan Triggers Immune Activation in Melanoma Patients. Frontiers in Oncology (2018).
  2. Locoregional management of in-transit metastasis in melanoma: an Ontario Health (Cancer Care Ontario) clinical practice guideline.. Current Oncology (2020).
  3. The Role of Regional Therapies for in-Transit Melanoma in the Era of Improved Systemic Options. Cancers (2015).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.